SPDR S&P Pharmaceuticals ETF (XPH): Price and Financial Metrics ETF
XPH Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
Current price | $41.94 | 52-week high | $48.76 |
Prev. close | $41.18 | 52-week low | $35.22 |
Day low | $41.67 | Volume | 324,363 |
Day high | $41.94 | Avg. volume | 51,435 |
50-day MA | $40.03 | Dividend yield | 1.6% |
200-day MA | $43.54 |
XPH Stock Price Chart Interactive Chart >
SPDR S&P Pharmaceuticals ETF (XPH) ETF Bio
The investment objective of the SPDR S&P Pharmaceuticals ETF is to provide investment results that correspond generally to the total return performance of the S&P Pharmaceuticals Select Industry Index.
XPH ETF Info
Issuer | State Street Global Advisors |
Expense Ratio | 0.35% |
Underlying Index | S&P Pharmaceuticals Select Industry Index |
Asset Class | Equity |
Sector | Health & Biotech ETFs |
Assets Under Management (AUM) | 141.92M |
Net Asset Value (NAV) | $41.13 |
Options? | Yes |
Total Holdings | 44 |
XPH Top Holdings
Symbol | Company | % of Total |
ELAN | ELANCO ANIMAL HEALTH INC | 5.13% |
CORT | CORCEPT THERAPEUTICS INC | 5.05% |
ZTS | ZOETIS INC | 4.14% |
RPRX | ROYALTY PHARMA PLC CL A | 4.04% |
PBH | PRESTIGE CONSUMER HEALTHCARE | 3.83% |
PRGO | PERRIGO CO PLC | 3.79% |
JNJ | JOHNSON + JOHNSON | 3.73% |
LLY | ELI LILLY + CO | 3.7% |
VTRS | VIATRIS INC | 3.69% |
PFE | PFIZER INC | 3.61% |
XPH Price Returns
1-mo | 5.27% |
3-mo | -5.28% |
6-mo | -8.42% |
1-year | 4.87% |
3-year | 2.51% |
5-year | 3.08% |
YTD | -2.10% |
2024 | 4.94% |
2023 | 2.97% |
2022 | -9.83% |
2021 | -10.54% |
2020 | 14.68% |
XPH Dividends
Ex-Dividend Date | Type | Payout Amount | Change | ||||||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |